Indications and Purposes
| 1 Indications And Usage Ultomiris Is Indicated For: The Treatment Of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (Pnh). The Treatment Of Adults And Pediatric Patients One Month Of Age And Older With Atypical Hemolytic Uremic Syndrome (Ahus) To Inhibit Complement-Mediated Thrombotic Microangiopathy (Tma). Ultomiris Is A Complement Inhibitor Indicated For: The Treatment Of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (Pnh) ( 1 ). The Treatment Of Adults And Pediatric Patients One Month Of Age And Older With Atypical Hemolytic Uremic Syndrome (Ahus) To Inhibit Complement-Mediated Thrombotic Microangiopathy (Tma) ( 1 ). Limitations Of Use: Ultomiris Is Not Indicated For The Treatment Of Patients With Shiga Toxin E. Coli Related Hemolytic Uremic Syndrome (Stec-Hus). Limitations Of Use: Ultomiris Is Not Indicated For The Treatment Of Patients With Shiga Toxin E. Coli Related Hemolytic Uremic Syndrome (Stec-Hus). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Ravulizumab |